Lv3
316 积分 2025-04-22 加入
T cell exhaustion
4天前
已完结
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
5天前
已完结
The Role of Siglec-15 in Tumor Immunity: Mechanisms and Therapy
29天前
已完结
Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy
1个月前
已完结
Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastases
1个月前
已完结
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
2个月前
已完结
CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling
4个月前
已完结
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study
4个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
4个月前
已完结
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
